ZonMw grants for group leaders Den Hertog, Mattiroli, Bakkers and Van Rooij
Jeroen den Hertog, Francesca Mattiroli, Jeroen Bakkers, and Eva van Rooij, group leaders at the Hubrecht Institute, have received ZonMw Open Competition grants. The grants allow them to delve deeper into their research on RASopathies and heart regeneration. You can learn more about their projects below.
UtrechtInc has been recognized in the Financial Times “Europe’s Leading Startup Hubs 2026” ranking.
While UtrechtInc is proud of this recognition, the real stars of the story are the entrepreneurs, researchers, and students who walk through its doors every day.
Jeroen Kingma to be the new Director of Campus & Facilities
As of 1 April 2026, Jeroen Kingma will be the new Director of the Campus & Facilities. In this role, he will lead the Campus & Facilities department and will be responsible for policy and implementation in the areas of real estate, accommodation and facility services. Kingma currently serves as Vice Chair of the Supervisory Board at Zorggroep Tangenborgh.
Utrecht Science Park Foundation is looking for a new Director-Executive
The current Director-Executive, Jan Henk van der Velden of the Utrecht Science Park Foundation, has announced that he will step down from his role as of July 1, 2026. In the coming period, a search will be conducted for an enthusiastic successor.
Full of energy toward the Utrecht Marathon: a successful running symposium filled with tips and inspiration
On March 19, the running symposium took place at UMC Utrecht, located at Utrecht Science Park, in the lead-up to the Utrecht Marathon on May 31. Many running enthusiasts who work or study at Utrecht Science Park attended the event that evening.
Report: Economic gains are more important than idealism in sustainability efforts
Queen Máxima today received the second edition of the State of Circular Entrepreneurship: a publication by Route Circulair in collaboration with Utrecht University of Applied Sciences and Eindhoven University of Technology. The report reveals a striking pattern: ambition around circularity is growing strongly, but the translation into concrete implementation is lagging behind.
GenDx and Treos Bio Announce Partnership to develop HLA-based Companion Diagnostic for PolyPEPI1018 Cancer Immunotherapy
GenDx, a Eurobio Scientific Company, based in the Netherlands, specialized in molecular diagnostics for transplantation, today announced a collaboration with Treos Bio, a UK based clinical stage
company, developing next generation of effective off-the-shelf peptide cancer immunotherapies. GenDx and Treos Bio will partner in the development and validation of an integrated companion
diagnostic (CDx) HLA-typing test for Treos Bio’s off-the-shelf peptide cancer immunotherapy candidate, PolyPEPI1018, for the treatment of microsatellite stable (MSS) colorectal cancer.
Alan Hanjalic new Dean Faculty of Science
From 1 July 2026, prof. dr. Alan Hanjalic has been appointed Dean of the Faculty of Science by the Executive Board of Utrecht University (UU). He will also be appointed professor at UU. Currently, Hanjalic is professor of Computer Science and head of the Intelligent Systems department at TU Delft.
Building energy independence at the Utrecht Science Park
At the Utrecht Science Park, five institutions are joining forces to develop a collective aquifer thermal energy storage system (ATES). With this initiative, they are taking an important step toward a future-proof, largely fossil-free energy system. A thermal source for heating and cooling is currently being installed to connect the first buildings. By 2030, several more buildings are expected to be linked to this shared infrastructure. By mutually sharing heat and cold, the campus will significantly reduce its reliance on natural gas and external energy sources.
First CAR-T therapy in systemic sclerosis at UMC Utrecht
For the first time in the Netherlands, a patient with systemic sclerosis has been treated with CAR-T cell therapy at the UMC Utrecht. The fact that CAR-T is now also being investigated for an inflammatory disease offers a whole new perspective on treatments for not only systemic sclerosis, but also other rheumatic diseases. The patient is taking part in an international clinical trial comparing CAR-T with rituximab, a drug often used in severe autoimmune diseases.
External review confirms strong research foundation at Veterinary Medicine
The Faculty of Veterinary Medicine at Utrecht University has a strong and coherent research foundation. Its research is internationally visible and societally relevant. This is confirmed by a recent evaluation by an external review committee. The final report also provides guidance for further strengthening the Faculty’s research.
Utrecht Science Park researchers receive prestigious Cancer Grand Challenge grants
Several research groups, including researchers from UMC Utrecht, the Princess Máxima Center, and the Hubrecht Institute, have been selected for a prestigious Cancer Grand Challenge (CGC) grant. Cancer Grand Challenges was co-founded in 2020 by Cancer Research UK and the National Cancer Institute in the United States. The initiative supports international, multidisciplinary research teams focusing on major challenges in cancer research.